Wall Street Analysts Are Bullish on Top NA Picks
Analysts from Monness and J.P. Morgan maintained Buy ratings on Meta Platforms (META) with price targets of $830 and $820, respectively. Micron (MU) received a Buy rating and $1540 price target from J.P. Morgan. Insmed (INSM) was rated Buy with a $175 target by J.P. Morgan. All three stocks have Strong Buy consensus ratings.
How this was made
The 30-second read
Why it matters
The new coverage could generate buying pressure across the three stocks, especially in the short term.
Market read
Analyst upgrades with higher targets provide a fresh catalyst that may move the stocks higher today.
What to watch
Potential supply‑chain constraints for Micron and regulatory risks for Insmed are not addressed.
Background
Three analysts issued fresh Buy ratings and higher price targets for META, MU, and INSM on the same day.
Ticker impact
Analyst Brian White maintained a Buy rating with a new $830 price target, higher than the current price of $751.66.
upward pressure as investors price in the higher target
The upgrade and higher target are fresh analyst opinions, providing a concrete catalyst for buying.
J.P. Morgan reiterated a Buy rating and set a $1,540 price target, above the recent close of $1,082.28.
upward pressure as the market absorbs the new target
The analyst’s fresh target is a primary piece of news that may attract buying interest.
J.P. Morgan analyst Jessica Fye reiterated a Buy rating with a $175 price target, above the last close of $117.83.
upward pressure as investors react to the upgraded outlook
The analyst’s fresh recommendation provides a specific catalyst for the stock.
Market effects
Positive analyst sentiment may lift the broader technology and healthcare sectors.
North American markets could see modest gains in related stocks.
Limited to US‑listed peers; no global macro impact.
Counterpoint
Some investors may view the high targets as overly optimistic given recent valuation levels.
Key entities
- analystBrian White
Monness analyst covering Meta Platforms
- analystHarlan Sur
J.P. Morgan analyst covering Micron
- analystJessica Fye
J.P. Morgan analyst covering Insmed
